| • New professional body
• Fitness to practise
• Medicines use reviews (MURs)
• Workload
• Disciplinary procedures
• Ergocalciferol
• Furosemide
• Ophthalmology
Letters to the Editor
|
New professional body
Transitional committee should start work now
From Mr I. G. Simpson, FRPharmS, and others
In our recent report “Forward from Waterloo”, we expressed
our broad agreement with the recommendations of the Clarke Inquiry. We
agree with Hemant Patel (PJ, 10 May 2008, p565) that we have
a unique opportunity to build a dynamic new professional body for pharmacy,
and
we fully support
his call for all pharmacists to take an interest and get engaged in the
transition process (ibid,
p555). We would like to see that invitation
extended to pharmacy students, pharmaceutical scientists and pharmacy
technicians.
We fully agree with Nigel Clarke (PJ, 17 May 2008, p583) that
it is absolutely vital that the transitional committee is set
up as soon as possible,
and we were concerned that the consultation proposed by the Society would
delay implementation of Clarke’s recommendations.
However, at the Guild of Healthcare Pharmacists and United Kingdom Clinical
Pharmacy Association national conference on 10 May 2008, we were pleased
to receive an assurance from the Royal Pharmaceutical Society’s
Chief Executive, Jeremy Holmes, that establishment of the transitional
committee
would run in parallel with the consultation.
In your report (PJ, 26 April 2008, p493), you identified those
organisations that wish to be an integral
part of the new professional body, and those
that wish to work closely with it. We are currently taking steps to identify
members who could contribute to the transitional committee, and our intention
is that each of the selected members will be supported by a reference
group and network. We look for a significant proportionate contribution
from the Waterloo Group to the transitional committee.
We are keen to work with the Society to ensure that we produce a prospectus
that will encourage all members of the pharmacy profession to join the
new professional body, and we urge the Society to appoint the independent
chairman and get the transitional committee established so that it can
start work immediately. As you say in your editorial (PJ, 17
May 2008, p582), it is a great opportunity for the Society’s Council
to send out a new message.
Ian Simpson
Chief Executive, College of Pharmacy Practice
David Wyatt
Chairman, Academy of Pharmaceutical Sciences
Sarah Wilcox
President, Association of Pharmacy Technicians UK
Steve Tomlin
Chairman, CPP Faculty of Neonatal and Paediatric Pharmacy
Stephen Guy
President, College of Mental Health Pharmacists
Richard Cattell
President, Guild of Healthcare Pharmacists
Howard McNulty
General Secretary, Institute of Pharmacy Management
Barry Strickland-Hodge
Chairman, CPP Faculty of Prescribing and Medicines Management
Beryl Bevan
Chairman Designate, Pharmaceutical Advisers Group
Rowena McArtney
Chairman, Neonatal and Paediatric Pharmacy Group
Paul Spark
Secretary, NHS Pharmaceutical Production Committee
Richard Bateman
Chairman, NHS Pharmaceutical Quality Assurance Committee
Clive Moss-Barclay
Chairman, NHS Pharmacy Education and Development Committee
Lynne Morrison
Chairman, NHS Technical Specialists Education and Training Group
Joy Wingfield
Chairman, Pharmacy Law and Ethics Association
Shailen Rao
Chairman, Primary Care Pharmacists Association
David Green
Chairman, Primary and
Community Care Pharmacy Network
Ray Fitzpatrick
Chairman, RPSGB Hospital Pharmacists Group
Geoff Saunders
Chairman, British Oncology Pharmacy Association Executive Committee,
and Chairman, CPP Faculty of Cancer Pharmacy
Michael Parker
Chairman, RPSGB Industrial Pharmacists Group
Andrew Cairns
Chairman, RPSGB Veterinary Pharmacists Group
Catherine Duggan
Chairman, UK Clinical Pharmacy Association
Eilish Smith
Chairman, UK Medicines Information Executive
Ian Maidment
Chairman, UK Psychiatric Pharmacy Group
Peter Rhodes
Chairman, NHS Pharmaceutical Aseptic Services Group
Paul Maltby
Chairman, UK Radiopharmacy Group |